|Videos|March 17, 2022

Dr. Min Dong discusses ongoing research with onabotulinumtoxinA for patients with urologic disease

“Botox has been a wonderful drug for many, many years,” says Min Dong, MD.

In this video, Min Dong, MD, summarizes the ongoing and future research related to Botox therapies for urologic diseases. These ideas stem from the talk he gave at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2022 Winter Meeting, titled, “New frontiers in therapeutic toxins for urologic disease.” Dong is an associate professor of urology at Harvard Medical School in Cambridge, Massachusetts.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!

Related Content

Latest CME

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment
Virtual Event

Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

February 23, 2026

View more
Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD
Video

Case-by-Case: Application of HIF-PHIs for the Treatment of Anemia in Patients With CKD

Glenn M. Chertow, MD, MPH; Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Preethi Yerram, MD

View more